SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006365
Filing Date
2024-02-14
Accepted
2024-02-14 09:15:18
Documents
17
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43743
2 ex1-1.htm EX-1.1 506945
3 ex5-1.htm EX-5.1 11732
4 ex99-1.htm EX-99.1 12046
  Complete submission text file 0001493152-24-006365.txt   857133

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aztr-20240213.xsd EX-101.SCH 3018
6 XBRL LABEL FILE aztr-20240213_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE aztr-20240213_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

IRS No.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 24632990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)